Aerovate Therapeutics, Inc.
AVTE
Revenue
0.00
0.000.00%
-Assets
80.33M
▼-10.63M▼-11.68%
3 Months ChangeLiabilities
3.90M
▼-6.57M▼-62.76%
3 Months ChangeFree Cash Flow
-11.44M
▼-5.75M▼-101.09%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-31
Form 8-K
ID: 0001104659-24-112896
2024-10-17
Form 8-K
ID: 0001798749-24-000055
2024-10-10
Form 8-K
ID: 0001798749-24-000052
2024-08-12
Form 10-Q
ID: 0001798749-24-000049
2024-07-08
Form 8-K
ID: 0001798749-24-000042
2024-06-28
Form 8-K
ID: 0001798749-24-000036
2024-06-17
Form 8-K
ID: 0001104659-24-072058
2024-06-07
Form 8-K
ID: 0001798749-24-000033
2024-05-13
Form 10-Q
ID: 0001558370-24-007985
2024-05-13
Form 8-K
ID: 0001798749-24-000029